Google
Trusted Resources: News & Events
Latest announcements and gatherings
MARAC Advisory Statement: Monoclonal Antibodies Against SARS-CoV-2
August 26, 2021 – The Sickle Cell Disease Association of America Medical and Research Advisory Committee has released a statement with updated COVID-19 guidance.
MARAC recommends that people with sickle cell disease should have access to monoclonal antibody (mAbs) treatment according to established guidelines, to prevent mild COVID from progressing to severe disease.
Read the full recommendations for providers, policy makers and patients.
+myBinderRelated Content
-
Preventing Strokes in Children with Sickle Cell Diseasehttps://www.youtube.com/watch?v=k6h7cb7S...
-
Readout From the First Lady’s Roundtable on Improving the Lives of Americans Living With Sickle Cell DiseaseFirst Lady Melania Trump and the Health ...
-
5 Tips To Help Prevent InfectionCommon illnesses, like the flu, can quic...
-
P.O.W.E.R. Community Based Organization TrainingCost: Free Starting Feb 6, 2020 12 PM ...
-
State Of The CONSORTIUM – Sickle Cell Community ConsortiumJoin the Sickle Cell Community Consortiu...
-
Assessing Disease Knowledge and Self-Management in Youth With Sickle Cell Disease Prior to TransitionIntroduction: Transition of medical car...
-
Annette AkinseteAnnette Akinsete is a consultant public ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.